IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice

被引:231
作者
Biedermann, T
Zimmermann, S
Himmelrich, H
Gumy, A
Egeter, A
Sakrauski, AK
Seegmüller, I
Voigt, H
Launois, P
Levine, AD
Wagner, H
Heeg, K
Louis, JA [1 ]
Röcken, M
机构
[1] Univ Lausanne, Inst Biochem, WHO Immunol Res & Training Ctr, Lausanne, Switzerland
[2] Univ Munich, Dept Dermatol & Allergol, D-80337 Munich, Germany
[3] Tech Univ Munich, Dept Microbiol, D-8000 Munich, Germany
[4] Univ Marburg, Dept Microbiol, Marburg, Germany
[5] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA
关键词
D O I
10.1038/ni725
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunity to infection with intracellular pathogens is regulated by interleukin 12 (IL-12), which mediates protective T helper type I (T(H)1) responses, or IL-4, which induces T(H)2 cells and susceptibility. Paradoxically, we show here that when present during the initial activation of dendritic cells (DCs) by infectious agents, IL-4 instructed DCs to produce IL-12 and promote T(H)1 development. This T(H)1 response established resistance to Leishmania major in susceptible BALB/c mice. When present later, during the period of T cell priming, IL-4 induced T(H)2 differentiation and progressive leishmaniasis in resistant mice. Because immune responses developed via the consecutive activation of DCs and then T cells, the contrasting effects of IL-4 on DC development and T cell differentiation led to immune responses that had opposing functional phenotypes.
引用
收藏
页码:1054 / 1060
页数:7
相关论文
共 56 条
[1]   Functional diversity of helper T lymphocytes [J].
Abbas, AK ;
Murphy, KM ;
Sher, A .
NATURE, 1996, 383 (6603) :787-793
[2]   THE ADJUVANT EFFECT OF INTERLEUKIN-12 IN A VACCINE AGAINST LEISHMANIA-MAJOR [J].
AFONSO, LCC ;
SCHARTON, TM ;
VIEIRA, LQ ;
WYSOCKA, M ;
TRINCHIERI, G ;
SCOTT, P .
SCIENCE, 1994, 263 (5144) :235-237
[3]   A critical role for interleukin 4 in activating alloreactive CD4T cells [J].
Bagley, J ;
Sawada, T ;
Wu, Y ;
Iacomini, J .
NATURE IMMUNOLOGY, 2000, 1 (03) :257-261
[4]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[5]  
Biedermann T, 2001, EUR J IMMUNOL, V31, P1582, DOI 10.1002/1521-4141(200105)31:5<1582::AID-IMMU1582>3.0.CO
[6]  
2-M
[7]  
BRADLEY LM, 1995, J IMMUNOL, V155, P1713
[8]   THE INDUCTION OF PROTECTIVE IMMUNITY TO LEISHMANIA-MAJOR IN THE BALB/C MOUSE BY INTERLEUKIN-4 TREATMENT [J].
CARTER, KC ;
GALLAGHER, G ;
BAILLIE, AJ ;
ALEXANDER, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (04) :779-782
[9]   Requirement for type 2 NO synthase for IL-12 signaling in innate immunity [J].
Diefenbach, A ;
Schindler, H ;
Röllinghoff, M ;
Yokoyama, WM ;
Bogdan, C .
SCIENCE, 1999, 284 (5416) :951-955
[10]   Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4 [J].
Ebner, S ;
Ratzinger, G ;
Krösbacher, B ;
Schmuth, M ;
Weiss, A ;
Reider, D ;
Kroczek, RA ;
Herold, M ;
Heufler, C ;
Fritsch, P ;
Romani, N .
JOURNAL OF IMMUNOLOGY, 2001, 166 (01) :633-641